Molecular Imaging of Brain Tumors Using Labeled Technetium-99m 1-Thio-D-Glucose.

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 15, 2020

Primary Completion Date

February 15, 2021

Study Completion Date

February 15, 2021

Conditions
BrainNeoplasms
Interventions
DRUG

SPECT or SPECT-CT with 99mTc-1-thio-D-glucose

One single intravenous injection of 99mTc-1-thio-D-glucose, followed by gamma camera imaging directly postinjection and after 2, 4, 6 and 24 hours.

Trial Locations (1)

Unknown

TomskNRMC, Tomsk

All Listed Sponsors
collaborator

Uppsala University

OTHER

lead

Tomsk National Research Medical Center of the Russian Academy of Sciences

OTHER

NCT04288518 - Molecular Imaging of Brain Tumors Using Labeled Technetium-99m 1-Thio-D-Glucose. | Biotech Hunter | Biotech Hunter